Head-to-head · Cost-Efficiency Index
Sumbare Wellness vs Lttl
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Sumbare Wellness
Shoppers comfortable with a floor price that's only confirmed after a clinical review, rather than a locked-in rate.
Visit Sumbare WellnessLttl
Shoppers who want every commitment tier priced openly before intake, and who will read which rung the headline came from.
Visit LttlThe verdict
Sumbare Wellness takes it, leading the Cost-Efficiency Index 58 to 55. Sumbare Wellness is a telehealth GLP-1 and peptide-therapy provider advertising 'plans from $199/mo,' explicitly contingent on provider review rather than guaranteed at booking. Lttl still earns a C — Shoppers who want every commitment tier priced openly before intake, and who will read which rung the headline came from.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Sumbare Wellness.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Sumbare Wellness | Lttl |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 55/100 |
| Semaglutide / mo | $199/mo (compounded) | $199/mo (compounded) |
| Tirzepatide / mo | $199/mo (compounded) | $279/mo (compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,388 |
| Tirzepatide / yr (modeled) | $2,388 | $3,348 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #292 | #295 |
Sumbare Wellness
58/100Where the value is
- Offers both semaglutide and tirzepatide plus a microdose program
- States clinical outcome averages (15% vs 20% body weight loss) on the pricing-adjacent page
- Claims 'no hidden fees' with pricing confirmed transparently after clinical review
The tradeoffs
- '$199/mo' is a floor, not a locked price -- actual cost is only confirmed after provider review
- No medical director or specific pharmacy partner named
Lttl
55/100Where the value is
- Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout, including the literal "$279/mo every month"
- Named medical advisory board (pharmacist, nurse practitioner, physical therapist) rather than zero disclosure
- Real LegitScript verification badge with a working certificate link
The tradeoffs
- Headline marketing price is a 12-month-prepay rate, not the true month-to-month cost — "Plans start at $129/mo" is $1,548 paid up front
- True cancel-anytime price is $199 semaglutide and $279 tirzepatide, 35–40% above the advertised "from" figures
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.